Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
Amin
R
R
Radiotherapy Department, Royal Devon and Exeter Hospital, England.
D001859:Bone Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D001932:Brain Neoplasms / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008175:Lung Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D012074:Remission Induction; D012077:Renal Artery
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone